BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

858 related articles for article (PubMed ID: 8729908)

  • 21. Evaluation of herpes simplex thymidine kinase mediated gene therapy in experimental pancreatic cancer.
    Mäkinen K; Loimas S; Wahlfors J; Alhava E; Jänne J
    J Gene Med; 2000; 2(5):361-7. PubMed ID: 11045430
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
    Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
    Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosis.
    Princen F; Lechanteur C; Lopez M; Gielen J; Bours V; Merville MP
    J Drug Target; 2000; 8(2):79-89. PubMed ID: 10852340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential chemosensitivity of breast cancer cells to ganciclovir treatment following adenovirus-mediated herpes simplex virus thymidine kinase gene transfer.
    Li PX; Ngo D; Brade AM; Klamut HJ
    Cancer Gene Ther; 1999; 6(2):179-90. PubMed ID: 10195885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration.
    Niranjan A; Moriuchi S; Lunsford LD; Kondziolka D; Flickinger JC; Fellows W; Rajendiran S; Tamura M; Cohen JB; Glorioso JC
    Mol Ther; 2000 Aug; 2(2):114-20. PubMed ID: 10947938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor activity and reporter gene transfer into rat brain neoplasms inoculated with herpes simplex virus vectors defective in thymidine kinase or ribonucleotide reductase.
    Boviatsis EJ; Scharf JM; Chase M; Harrington K; Kowall NW; Breakefield XO; Chiocca EA
    Gene Ther; 1994 Sep; 1(5):323-31. PubMed ID: 7584098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
    Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
    Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals.
    Su H; Lu R; Ding R; Kan YW
    Mol Ther; 2000 Jun; 1(6):509-15. PubMed ID: 10933975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells.
    Takamiya Y; Short MP; Ezzeddine ZD; Moolten FL; Breakefield XO; Martuza RL
    J Neurosci Res; 1992 Nov; 33(3):493-503. PubMed ID: 1335091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of costimulatory molecules: B7 and ICAM up-regulation after treatment with a suicide gene.
    Ramesh R; Munshi A; Abboud CN; Marrogi AJ; Freeman SM
    Cancer Gene Ther; 1996; 3(6):373-84. PubMed ID: 8988840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCR-ABL-expressing cells transduced with the HSV-tk gene die by apoptosis upon treatment with ganciclovir.
    Rivas C; Miller AR; Collado M; Lam EW; Apperley JF; Melo JV
    Mol Ther; 2001 May; 3(5 Pt 1):642-52. PubMed ID: 11356068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term survival in a rodent brain tumor model by bradykinin-enhanced intra-arterial delivery of a therapeutic herpes simplex virus vector.
    Rainov NG; Dobberstein KU; Heidecke V; Dorant U; Chase M; Kramm CM; Chiocca EA; Breakefield XO
    Cancer Gene Ther; 1998; 5(3):158-62. PubMed ID: 9622099
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of herpes simplex virus thymidine kinase gene transduction and prodrug on ovarian cancer cell].
    Liang Z; Kuang J; Lin Z
    Zhonghua Fu Chan Ke Za Zhi; 1997 Aug; 32(8):467-70. PubMed ID: 9639739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resistance developing after long-term ganciclovir prodrug treatment in a preclinical model of NSCLC.
    Kurdow R; Schniewind B; Boehle AS; Haye S; Boenicke L; Dohrmann P; Kalthoff H
    Anticancer Res; 2004; 24(2B):827-31. PubMed ID: 15161034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune-dependent distant bystander effect after adenovirus-mediated suicide gene transfer in a rat model of liver colorectal metastasis.
    Agard C; Ligeza C; Dupas B; Izembart A; El Kouri C; Moullier P; Ferry N
    Cancer Gene Ther; 2001 Feb; 8(2):128-36. PubMed ID: 11263528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer.
    Galipeau J; Li H; Paquin A; Sicilia F; Karpati G; Nalbantoglu J
    Cancer Res; 1999 May; 59(10):2384-94. PubMed ID: 10344748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protease pretreatment increases the efficacy of adenovirus-mediated gene therapy for the treatment of an experimental glioblastoma model.
    Kuriyama N; Kuriyama H; Julin CM; Lamborn KR; Israel MA
    Cancer Res; 2001 Mar; 61(5):1805-9. PubMed ID: 11280727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine.
    Okada H; Giezeman-Smits KM; Tahara H; Attanucci J; Fellows WK; Lotze MT; Chambers WH; Bozik ME
    Gene Ther; 1999 Feb; 6(2):219-26. PubMed ID: 10435106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular imaging with 123I-FIAU, 18F-FUdR, 18F-FET, and 18F-FDG for monitoring herpes simplex virus type 1 thymidine kinase and ganciclovir prodrug activation gene therapy of cancer.
    Wang HE; Yu HM; Liu RS; Lin M; Gelovani JG; Hwang JJ; Wei HJ; Deng WP
    J Nucl Med; 2006 Jul; 47(7):1161-71. PubMed ID: 16818951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.